Also Read
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Policy.
Medically Verified By: Dr. Suresh Raghavaiah
What is fatty pancreas? Read on to know!
In recent decades, urban India has witnessed a dramatic shift in its health profile. While we have become all too familiar with the terms "Fatty Liver" and "Metabolic Syndrome" during our annual health checkups, Medical scans in cities like Bengaluru, Gurugram, and Delhi are discovering that fat is also accumulating in the pancreas. This new, equally stealthy condition is Fatty Pancreas. Fatty Pancreas Disorder, also known as pancreatic steatosis or non-alcoholic fatty pancreas disease, is characterized by the abnormal accumulation of fat within the pancreatic tissue. Unlike the liver, where fat accumulates primarily inside the cells, fat in the pancreas often infiltrates the spaces between the pancreatic cells or replaces healthy cells that have died due to chronic inflammation.
In an exclusive interaction with TheHealthSite.com, Dr. Suresh Raghavaiah, Liver Transplant Surgeon and HPB surgeon, Apollo Hospitals, Bannerghatta Road, Bangalore, explained that the pancreas is a dual-purpose organ tucked behind the stomach with two critical jobs: it produces digestive enzymes to break down food and secretes hormones like insulin to regulate blood sugar levels. When fat begins to clog this organ, it can interfere with both functions, potentially leading to long-term metabolic complications. As obesity and Type 2 Diabetes reach epidemic proportions across the country, it is important to recognize and treat this under-recognized entity.
A fatty pancreas is not new and was actually described in literature as early as 1933 by researcher Ogilvie. Now almost a century later the implications of a fatty pancreas are being studied in more detail. While determining the exact incidence of Fatty Pancreas in India is challenging, global data suggests a fatty pancreas affects about one-fifth of the general population with the numbers particularly concerning for the Asian population. A major systematic review revealed that over half of patients who already have a fatty liver also have a fatty pancreas. In Asian-specific studies, the prevalence is estimated at approximately 35.59%, a figure that highlights the susceptibility of the Asian population. Research also shows that the risk increases linearly with age and obesity, with fat content often rising significantly after the age of 60.
These results mirror the incidence of fatty liver due to our genetic susceptibility to store visceral fat. The relationship between Fatty Pancreas Disease and Fatty Liver Disease is so close that they are increasingly viewed as parallel manifestations of systemic metabolic dysfunction
Current studies also show that nearly 97% of patients with a fatty liver also have a fatty pancreas, whereas only about 68% of those with a fatty pancreas have a fatty liver. This implies that fat may begin to accumulate in the pancreas much earlier in the metabolic dysfunction timeline than it does in the liver. As fatty liver currently affects nearly one-third of the global population, the silent spread of Fatty Pancreas in India, often termed the "diabetes capital of the world" is likely reaching epidemic proportions.
Healthcare providers often observe that Fatty Pancreas and Fatty Liver are metabolic siblings. Many patients develop both conditions simultaneously because they share common risk factors. The surge of this condition in India is largely driven by modern lifestyle changes. Obesity and excess visceral (belly) fat are the strongest predictors of fat deposition in the pancreas. The shift toward "Westernized" high-calorie diets which are rich in refined carbohydrates, sugary beverages, and saturated fats like those found in processed snacks is a possibly the most important contributor. Sedentary habits and a lack of physical activity further impair the body's ability to process fats and sugars. Beyond lifestyle, aging and genetic predispositions can also make certain individuals more susceptible to metabolic disorders affecting the pancreas. The association between Fatty Pancreas Disease and Metabolic Syndrome is so strong that some experts suggest it should be considered the "fifth component" of the syndrome.
A fatty pancreas is no longer an "Incidental Finding" on scans. It is a precursor for multiple conditions, most importantly Type 2 Diabetes, where the pancreas fails to regulate sugar levels due to damage to the insulin producing cells. The worrisome fact is that a 25% increase in pancreatic fat content has been shown to significantly raise the risk of both Type 2 Diabetes and generalized atherosclerosis. Patients who have both fatty pancreas and metabolic syndrome are more likely to suffer from Hypertension, Atherosclerosis and abnormal lipid profile (High Triglycerides and low HDL(Good Cholesterol))
The patient is also at a higher risk of developing pancreatitis because the fat in the pancreas causes a toxic microenvironment by releasing harmful chemicals (Cytokines) which leads to inflammation. Perhaps the most worrisome complication we need to worry is the development of Pancreatic cancer. Analyses of Pancreatic specimens have shown a 6 fold more deposition of fat in pancreatic cancer specimens vs other diseases!! A patient with a fatty pancreas also has a higher risk of developing post surgical complications after any pancreatic surgery. It also places the patient at a higher heart attack risk as patients with both fatty liver and fatty pancreas often suffer from hypertension and atherosclerosis.
The most dangerous aspect of Fatty Pancreas is its silence. In its early stages, the condition is often entirely asymptomatic and is frequently discovered as an "incidental finding" during abdominal imaging for unrelated issues. However, as the fat accumulation advances, it can manifest through several non-specific symptoms often related to the organ's failure to produce digestive enzymes, known as exocrine pancreatic insufficiency. Patients may experience bloating, stomach discomfort, and steatorrhea (oily, foul-smelling stools that are difficult to flush). The patient may also have unexplained fatigue, weakness, and unintended weight loss despite a normal diet. Once Endocrine insufficiency sets in, the patient develops all symptoms of diabetes including sugar spikes and difficult to manage sugar levels.
The most often used test to detect fatty pancreas is an Ultrasound scan where a fatty pancreas appears "brighter" than the liver or kidneys. However, it is less accurate in obese patients. A CT Scan may potentially show areas of low density where fat has replaced healthy tissue. The current gold standard investigation to detect a Fatty Pancreas is a Magnetic Resonance Imaging, specifically Proton Density Fat Fraction (PDFF) MRI. It is very sensitive and most specific test to both diagnose and quantify exactly how much fat is in the organ. It allows us to identify fatty pancreas disease in its infancy, providing a unique window of opportunity to intervene before any complications occur.
The good news is that, like fatty liver, a fatty pancreas is often reversible, especially when caught early. And unlike the permanent scarring seen in advanced cirrhosis of liver, pancreatic fat is highly dynamic and can be completely healed, reversing the risk of all complications.
Lifestyle changes is the first line of defense. For the Indian audience, prevention must start in the kitchen and the daily routine. Avoidance of highly processed and High calorie food, sodas, and sugary beverages, increasing the intake of fiber in the form of whole grains and vegetables, strict abstinence from smoking and alcohol intake and a daily exercise routine of 20mins/day or 150 mins/week are the corner stones of reversal. Losing even 5 10% of body weight can significantly reduce triglyceride content in the pancreas and restore its function. In cases of severe obesity, bariatric surgery has shown dramatic results, with some patients seeing a 26% to 35% reduction in pancreatic fat within a year. It is also important that on routine health check-ups, If you have been diagnosed with a fatty liver or metabolic syndrome, to talk to your doctor about screening for pancreatic health as well.
Pharmacological options are also emerging. While there is no "magic pill" specifically for treating Fatty Pancreas, several medications used for weight loss and diabetes are showing promise including the Newer "weight loss injections" like semaglutide and tirzepatide which have demonstrated the ability to cause significant overall weight loss, which in turn reduces organ fat. The diabetes medication PIoglitazobe may help improve insulin sensitivity and reduce the flow of fatty acids to the pancreas thus preventing or treating fatty Pancreas.
The rise of the fatty pancreas is a wake-up call for modern India. The presence of a fatty pancreas is not an isolated finding but a hallmark of systemic metabolic dysfunction While advanced diagnostic tools are becoming more available, the real treatment lies in our daily choices. By maintaining a healthy weight, staying active, and choosing traditional, whole-food-based diets, we can protect this vital organ. If you have been diagnosed with a fatty liver or struggle with persistent indigestion and "borderline" blood sugar, it is time to consult a specialist for a comprehensive evaluation. If metabolic syndrome is a falling sequence of tiles, the pancreas is often the unseen force that tips the first domino. Early detection is no longer about finding a problem too late; it is about reclaiming the health of an organ we've ignored for far too long.